Stott Daniel, Bolten Mareike, Salman Mona, Paraschiv Daniela, Clark Katherine, Kametas Nikos A
Division of Women's Health, King's College Hospital, Antenatal Hypertension Clinic, London, UK.
Division of Women's Health, King's College Hospital, Harris Birthright Research Centre for Fetal Medicine, London, UK.
Acta Obstet Gynecol Scand. 2016 Mar;95(3):329-38. doi: 10.1111/aogs.12823. Epub 2016 Jan 3.
Fetal growth restriction (FGR) is associated with poor perinatal outcomes. Screening and prevention tools for FGR, such as uterine artery Doppler imaging and aspirin, underperform in high-risk groups, compared with general antenatal populations. There is a paucity of sensitive screening tests for the early prediction of FGR in high-risk pregnancies.
This was a prospective observational study based in a dedicated antenatal hypertension clinic at a tertiary UK hospital. We assessed maternal demographic and central hemodynamic variables as predictors for FGR in a group of women at high risk for placental insufficiency due to chronic hypertension (n = 55) or a history of hypertension in a previous pregnancy (n = 71). Outcome variables were birthweight z-score as well as development of FGR (defined as birthweight below the 5th or 3rd centile). Maternal hemodynamics were assessed using a noninvasive transthoracic bioreactance monitor (Cheetah NICOM).
The mean gestation at presentation was 13.6 (range: 8.5-19.5) weeks. Sixteen women delivered babies below the 5th centile. Ten of these were below the 3rd centile. Independent predictors of birthweight z-score were body surface area, peripheral vascular resistance and white ethnicity (R(2) = 0.26, p < 0.0001). Independent predictors of FGR were maternal height and cardiac output. The area under the receiver operator characteristic curve for prediction of FGR was 0.915 (95% CI 0.859-0.972) and 0.9079 (95% CI 0.823-0.990) for FGR below the 5th and 3rd centiles, respectively.
In women with chronic hypertension or a history of hypertension in a previous pregnancy, maternal size and cardiac output at booking provide a sensitive screening tool for FGR.
胎儿生长受限(FGR)与围产期不良结局相关。与一般产前人群相比,FGR的筛查和预防工具,如子宫动脉多普勒成像和阿司匹林,在高危人群中的表现欠佳。对于高危妊娠中FGR的早期预测,缺乏敏感的筛查试验。
这是一项前瞻性观察性研究,在英国一家三级医院的专门产前高血压诊所进行。我们评估了一组因慢性高血压(n = 55)或既往妊娠有高血压病史(n = 71)而存在胎盘功能不全高危因素的女性的产妇人口统计学和中心血流动力学变量,作为FGR的预测指标。结局变量为出生体重z评分以及FGR的发生情况(定义为出生体重低于第5或第3百分位数)。使用无创经胸生物反应监测仪(猎豹NICOM)评估产妇血流动力学。
就诊时的平均孕周为13.6周(范围:8.5 - 19.5周)。16名女性分娩的婴儿体重低于第5百分位数。其中10名低于第3百分位数。出生体重z评分的独立预测因素为体表面积、外周血管阻力和白人种族(R² = 0.26,p < 0.0001)。FGR的独立预测因素为产妇身高和心输出量。预测FGR低于第5百分位数和第3百分位数时,受试者工作特征曲线下面积分别为0.915(95%可信区间0.859 - 0.972)和0.9079(95%可信区间0.823 - 0.990)。
对于有慢性高血压或既往妊娠有高血压病史的女性,孕早期的产妇身材和心输出量为FGR提供了一种敏感的筛查工具。